June 1 - 2 2026
Renaissance Seaport District, Boston, MA
As the Vice President of the GLP-1 Portfolio, Ed oversees the commercial success of a core portfolio of Novo Nordisk brands including Victoza, Ozempic, and future GLP-1 products.
Over the course of his 15 year career at Novo Nordisk, Ed has held numerous sales and marketing positions within the commercial organization including: brand management and leadership across multiple brands and product launches in both diabetes and obesity, District Sales Manager, and VP of Sales Execution & Operations. Most recently Ed oversaw the launch of the Ozempic brand.
Prior to his career in pharma, Ed worked on Wall Street in real estate finance and as a consultant to large, institutional investment banks for fixed income products.
Ed earned a BS in Finance from Lehigh University, an MBA in Marketing and Finance from Fordham University, and a Certificate of Professional Development from The Wharton School of the University of Pennsylvania.
Check out the incredible speaker line-up to see who will be joining Ed.
Download The Latest Agenda